Production (Stage)
ESSA Pharma Inc.
EPIX
$1.67
-$0.03-1.77%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -7.45% | 20.08% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -23.78% | 25.87% | |||
| Operating Income | 23.78% | -25.87% | |||
| Income Before Tax | 25.28% | -34.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.28% | -34.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.28% | -34.25% | |||
| EBIT | 23.78% | -25.87% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 25.29% | -34.22% | |||
| Normalized Basic EPS | 25.23% | -34.19% | |||
| EPS Diluted | 25.29% | -34.22% | |||
| Normalized Diluted EPS | 25.23% | -34.19% | |||
| Average Basic Shares Outstanding | 0.00% | 0.05% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||